Srisomboon Jatupol, Phongnarisorn Chailert, Suprasert Prapaporn, Cheewakriangkrai Chalong, Siriaree Sitthicha, Charoenkwan Kittipat
Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Thailand.
J Obstet Gynaecol Res. 2002 Jun;28(3):149-53. doi: 10.1046/j.1341-8076.2002.00027.x.
To evaluate the postoperative morbidity and lymphocyst formation in invasive cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy (RHPL) with no drainage and no peritonization compared with retroperitoneal drainage and peritonization.
Between July 1999 and May 2000, 100 patients with stage IA-IIA cervical cancer undergoing RHPL in Chiang Mai University Hospital were prospectively randomized to receive either no peritonization and no drainage (Group A = 48 cases) or retroperitoneal drainage and peritonization (Group B = 52 cases). Perioperative data and morbidity were recorded. Transabdominal and transvaginal sonography were performed at 4, 8 and 12 weeks postoperatively to detect lymphocyst formation.
Both groups were similar regarding age, size and gross appearance of tumor, tumor histology and stage. There was no difference between groups in respect of operative time, need for blood transfusion, intraoperative complications, hospital stay, number of nodes removed, nodal metastases, and need for adjuvant radiation and chemotherapy. Asymptomatic lymphocysts were sonographically detected at 4, 8 and 12 weeks postoperatively in 3 (6.8%), 2 (4.6%), and 3 (7.7%) of 44, 43, and 39 patients, respectively in Group A, whereas none was found in Group B (P = 0.2). No significant difference was found in term of postoperative morbidity in the two groups.
Routine retroperitoneal drainage and peritonization after RHPL for invasive cervical cancer can be safely omitted.
评估与行腹膜后引流及腹膜化的根治性子宫切除术和盆腔淋巴结清扫术(RHPL)相比,未行引流及腹膜化的浸润性宫颈癌患者术后的发病率及淋巴囊肿形成情况。
1999年7月至2000年5月期间,清迈大学医院100例IA-IIA期宫颈癌患者前瞻性随机分组,分别接受未行腹膜化及引流(A组 = 48例)或腹膜后引流及腹膜化(B组 = 52例)。记录围手术期数据及发病率。术后4周、8周和12周进行经腹及经阴道超声检查以检测淋巴囊肿形成情况。
两组在年龄、肿瘤大小及外观、肿瘤组织学类型及分期方面相似。两组在手术时间、输血需求、术中并发症、住院时间、切除淋巴结数量、淋巴结转移情况以及辅助放疗和化疗需求方面无差异。A组44例、43例和39例患者中,分别在术后4周、8周和12周超声检测到无症状淋巴囊肿的患者有3例(6.8%)、2例(4.6%)和3例(7.7%),而B组未发现(P = 0.2)。两组术后发病率无显著差异。
浸润性宫颈癌RHPL术后可安全省略常规腹膜后引流及腹膜化操作。